We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-29.32%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
AUM
$44.2M
AUM Growth
-$11.5M
Cap. Flow
+$8.02M
Cap. Flow %
18.13%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$8.02M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIC icon
1
Oric Pharmaceuticals
ORIC
$1.44B
$19.8M 44.67%
3,540,777
SRZN icon
2
Surrozen
SRZN
$282M
$17.5M 39.54%
1,499,773
+689,685
+85% +$8.02M
TNYA icon
3
Tenaya Therapeutics
TNYA
$163M
$5.36M 12.12%
9,400,290
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$1.62M 3.67%
166,077
RVMD icon
5
Revolution Medicines
RVMD
$43.7B
$1.63K ﹤0.01%
46

Similar funds

Column Group's Q1 2025 Portfolio in Review

As of Q1 2025, Column Group held 5 positions worth $44.2M, down 21% from $55.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group deployed $8.02M of net new capital in Q1 2025, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group added most to Surrozen in Q1 2025, an estimated $8.02M increase.
  • Column Group's ten largest holdings make up 100% of its $44.2M portfolio in Q1 2025.
  • Column Group opened 0 new positions and closed 0 in Q1 2025.
  • Column Group's portfolio value fell 21% quarter-over-quarter to $44.2M.

Based on Column Group's 13F filing for Q1 2025, filed 14 May 2025.